Does sacituzumab-govitecan act as a conventional antibody drug conjugate (ADC), a prodrug of SN-38 or both?
Daniel V. Santi, Luc Cabel, François‐Clément Bidard
Topics & Concepts
ProdrugConjugateAntibody-drug conjugateDrugPharmacologyMedicineAntibodyChemistryMonoclonal antibodyImmunologyMathematicsMathematical analysisHER2/EGFR in Cancer ResearchCancer therapeutics and mechanismsMonoclonal and Polyclonal Antibodies Research